Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Gall

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Pulmonary Circulation|October 22, 2020
Advanced risk stratification of intermediate risk group in pulmonary arterial hypertensionAthiththan Yogeswaran, Manuel J Richter, Natascha Sommer, et al.
Biomed Research International|January 17, 2017
Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary HypertensionDirk Bandorski, Harilaos Bogossian, Johanna Stempfl, et al.
Pulmonary Circulation|October 8, 2019
Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute studyManuel J Richter, Jun Wan, Hossein A Ghofrani, et al.
Pulmonary Circulation|September 30, 2016
An international physician survey of pulmonary arterial hypertension managementIoana R Preston, Barbara Hinzmann, Sabina Heinz, et al.
Pulmonary Circulation|January 17, 2017
An international physician survey of chronic thromboembolic pulmonary hypertension managementHenning Gall, Ioana R Preston, Barbara Hinzmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 27, 2017
Hemodynamic phenotyping based on exercise catheterization predicts outcome in patients with heart failure and reduced ejection fractionAndreas Rieth, Manuel Jonas Richter, Henning Gall, et al.
Lung|May 19, 2017
Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial HypertensionVeronika Wetzl, Svenja Lena Tiede, Lothar Faerber, et al.
Stem Cell Research|August 13, 2021
Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-frame deletion in exon 3 and a missense mutation in exon 11 of the BMPR2 geneAbdulai Usman, Alexandra Haase, Sylvia Merkert, et al.
Respiratory Research|July 22, 2005
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitorsRalph Theo Schermuly, Christiane Inholte, Hossein Ardeschir Ghofrani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 5, 2016
The prognostic impact of thyroid function in pulmonary hypertensionManuel J Richter, Natascha Sommer, Ralph Schermuly, et al.
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Pulmonary Circulation|October 22, 2020
Advanced risk stratification of intermediate risk group in pulmonary arterial hypertensionAthiththan Yogeswaran, Manuel J Richter, Natascha Sommer, et al.
Biomed Research International|January 17, 2017
Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary HypertensionDirk Bandorski, Harilaos Bogossian, Johanna Stempfl, et al.
Pulmonary Circulation|October 8, 2019
Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute studyManuel J Richter, Jun Wan, Hossein A Ghofrani, et al.
Pulmonary Circulation|September 30, 2016
An international physician survey of pulmonary arterial hypertension managementIoana R Preston, Barbara Hinzmann, Sabina Heinz, et al.
Pulmonary Circulation|January 17, 2017
An international physician survey of chronic thromboembolic pulmonary hypertension managementHenning Gall, Ioana R Preston, Barbara Hinzmann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 27, 2017
Hemodynamic phenotyping based on exercise catheterization predicts outcome in patients with heart failure and reduced ejection fractionAndreas Rieth, Manuel Jonas Richter, Henning Gall, et al.
Lung|May 19, 2017
Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial HypertensionVeronika Wetzl, Svenja Lena Tiede, Lothar Faerber, et al.
Stem Cell Research|August 13, 2021
Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-frame deletion in exon 3 and a missense mutation in exon 11 of the BMPR2 geneAbdulai Usman, Alexandra Haase, Sylvia Merkert, et al.
Respiratory Research|July 22, 2005
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitorsRalph Theo Schermuly, Christiane Inholte, Hossein Ardeschir Ghofrani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 5, 2016
The prognostic impact of thyroid function in pulmonary hypertensionManuel J Richter, Natascha Sommer, Ralph Schermuly, et al.
Pageof 15